Tradestie Institutional Equity Comparison Engine

MTNB vs EQ โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

EQ Overall Edge

EQ Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Equillium, Inc. Common Stock (EQ) driven by superior Valuation, Growth & Margin, Options & Structure while MTNB counters with relative strength in Momentum & Technical. Fundamentally, MTNB trades at N/M Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus EQ at 1.5x Forward P/E and 0.0% operating margin (-52.3% YoY). In options structure, MTNB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against EQ sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner EQ
MTNB N/M vs EQ 1.5x Fwd P/E
Growth & Margin Winner EQ
Op Margin 0.0% vs 0.0% ยท YoY -100.0% vs -52.3%
Momentum & Technical Winner MTNB
1Y -31.4% vs +12.0% ยท 52W Pos 22% vs 11%
Options & Structure Winner EQ
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (100th %ile IV)
MTNB NYSE American
Matinas BioPharma Holdings, Inc.
Pharmaceutical Preparations
$0.81
-10.98% 1D
Market Cap $979,904
1M Return -46.7%
1Y Return -31.35%
Forward P/E N/M
Unified AI Score
54.6 / 100 HOLD
Tech 53.0 Fund 58.0 Flow 50.0 Mom 60.0
EQ NASDAQ
Equillium, Inc. Common Stock
Pharmaceutical Preparations
$1.12
+1.82% 1D
Market Cap $90.6M
1M Return -21.13%
1Y Return +12.0%
Forward P/E 1.5x
Unified AI Score
48.0 / 100 HOLD
Tech 30.0 Fund 51.0 Flow 63.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MTNB -31.35% EQ +12.0% Spread: +43.35 pp (EQ Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period MTNB Revenue EQ Revenue MTNB Op. Margin EQ Op. Margin Margin Edge
FY2017 $0M N/A -11024.6% N/A MTNB
FY2018 $0M N/A -12230.9% N/A MTNB
FY2019 $0M N/A -21067.4% N/A MTNB
FY2020 $0M N/A -15288.4% N/A MTNB
FY2021 $0M N/A -74954.5% N/A MTNB
FY2022 $0M $20M -771.3% -393.9% EQ
FY2023 $0M $40M -2168.4% -40.2% EQ
FY2024 N/A $40M N/A -20.1% EQ

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MTNB (2) vs EQ (6)
Institutional Metric MTNB EQ Criterion Row Winner
Market Capitalization Scale $979,904 $90.6M Larger Scale EQ
Trailing P/E Ratio Valuation N/M 1.5x Lower Multiple EQ
Forward P/E Ratio Valuation N/M 1.5x Lower Multiple EQ
Revenue Growth (YoY) Growth -100.0% -52.3% Higher Growth EQ
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -147.5% -59.0% Higher ROE EQ
52-Week Range Position Momentum 22% ($0โ€“$3) 11% ($1โ€“$4) Stronger Trend MTNB
Beta / 30D Volatility Risk Regime -7.20ฮฒ ยท 147% Vol 1.53ฮฒ ยท 93% Vol Lower Realized Risk EQ
Unified Institutional Score Composite Signal 54.6 / 100 (HOLD) 48.0 / 100 (HOLD) Higher Composite MTNB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MTNB vs EQ Buy Guide
MTNB UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MTNB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
EQ UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live EQ Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MTNB nor EQ registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.